Pulmonx Co. (NASDAQ:LUNG) Receives $13.36 Consensus PT from Brokerages

Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine brokerages that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month […]

Leave a Reply

Your email address will not be published.

Previous post Head to Head Survey: Viking (VIK) & Its Peers
Next post Head to Head Analysis: InvenTrust Properties (NYSE:IVT) and FrontView REIT (NYSE:FVR)